Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-22-033084)

Filing Details

Accession Number:: 0001493152-22-033084
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-21 14:49:48
Reporting Period:: 2022-11-17

Accepted Time:: 2022-11-21 14:49:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335105	Lixte Biotechnology Holdings Inc.	LIXT	Pharmaceutical Preparations (2834)	202903526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1650389	Eric Forman	680 E. Colorado Blvd., Suite 180 Pasadena CA 91101	Vice President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-17	4,852	$0.54	81,935	No	4	P	Indirect	Eric Forman Revocable Trust
Common Stock	Acquisiton	2022-11-18	7,648	$0.57	89,583	No	4	P	Indirect	Eric Forman Revocable Trust
Common Stock	Acquisiton	2022-11-18	2,500	$0.56	92,083	No	4	P	Indirect	Eric Forman Revocable Trust
Common Stock	Acquisiton	2022-11-18	6,059	$0.56	98,142	No	4	P	Indirect	Eric Forman Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Eric Forman Revocable Trust
No	4	P	Indirect	Eric Forman Revocable Trust
No	4	P	Indirect	Eric Forman Revocable Trust
No	4	P	Indirect	Eric Forman Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	38,598	Direct